Draw
|
Currency :
Structure Search
AG003A2V
33419-42-0 | (5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one
![Chemical structure of (5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, CAS 33419-42-0](https://api.angenesci.com/structure/156/33419-42-0.png)
AG003A2V
SDS
COATIP
This product is typically in stock.Please contact us for
quotation.
Request For Quotation
- mg
- g
- kg
- ml
- L
No data
- mg
- g
- kg
- ml
- L
No data
No data
| CAS Number | 33419-42-0 |
| Catalog Number | AG003A2V(AGN-PC-0R8Y9U) |
| Chemical Name | (5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one |
| EC Number | 251-509-1 |
| IUPAC Name | (5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one |
| InChI | InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1 |
| InChI Key | VJJPUSNTGOMMGY-MRVIYFEKSA-N |
| MDL Number | MFCD00869325 |
| Molecular Formula | C29H32O13 |
| Molecular Weight | 588.5566 |
| SMILES | O=C2OC[C@]1([H])[C@H](O[C@H]6[C@@H]([C@H]([C@@H]([C@@H](CO7)O6)O[C@@H]7C)O)O)C4=C(C=C3OCOC3=C4)[C@@H]([C@@]5=CC(OC)=C(O)C(OC)=C5)[C@]12[H] |
| UNII | 6PLQ3CP4P3 |
| Synonyms | alpha-D-Glucopyranosyl Isomer Etoposide,
Celltop,
Demethyl Epipodophyllotoxin Ethylidine Glucoside,
Eposide,
Eposin,
Eto GRY,
Eto-GRY,
Etomedac,
Etopos,
Etoposide,
Etoposide Pierre Fabre,
Etoposide Teva,
Etoposide, (5a alpha)-Isomer,
Etoposide, (5a alpha,9 alpha)-Isomer,
Etoposide, (5S)-Isomer,
Etoposide, alpha D Glucopyranosyl Isomer,
Etoposide, alpha-D-Glucopyranosyl Isomer,
Etoposido Ferrer Farma,
Exitop,
Lastet,
NSC 141540,
NSC-141540,
NSC141540,
Onkoposid,
Riboposid,
Teva, Etoposide,
Toposar,
Vépéside Sandoz,
Vépéside-Sandoz,
Vepesid,
VP 16,
VP 16 213,
VP 16-213,
VP 16213,
VP-16,
VP16,
etoposide,
VePesid,
Toposar,
trans-Etoposide,
33419-42-0,
Lastet,
(-)-Etoposide,
Zuyeyidal,
Etoposidum,
Etoposido,
Vepesid J,
Eposin,
Etoposidum [INN-Latin],
VP-16,
Etoposide (VP16),
VP 16-213,
Etoposido [INN-Spanish],
VP 16 (pharmaceutical),
Etopophos (phosphate salt),
VP 16,
VP-16-213,
4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside,
VP 16213,
UNII-6PLQ3CP4P3,
NK 171,
NSC 141540,
CCRIS 2392,
HSDB 6517,
4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside),
EINECS 251-509-1,
NSC-141540,
6PLQ3CP4P3,
Epipodophyllotoxin VP-16213,
Vepeside,
CHEMBL44657,
CHEBI:4911,
Demethylepipodophyllotoxin-beta-D-ethylideneglucoside,
4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin,
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside),
CPD000112002,
EPEG,
Epipodophyllotoxin-beta-D-ethyliden-glucoside, 4'-demethyl-,
Eposide,
4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside),
Etosid,
[1,3]benzodioxol-8-one,
(5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside,
9-((4,6-O-Ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-,
9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4- hydroxy-3,4-dimethyloxyphenyl)furo (3',4'':6,7) naptho-(2,3-d)-1,3-dioxol-6 (5aH)-one,
Etopol,
C29H32O13,
MFCD00869325,
NSC141540,
Etoposide (VP-16),
(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one,
9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one,
Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 9-((4,6-O-(1R)-ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-,
Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one-, 9-((4,6-O-ethylidene-beta-D-glucopyranosyl)oxy)5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl), (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-,
SMR000112002,
Demethyl-epiodophyllotoxin ethylidene glucoside,
Etoposide [USAN:INN:BAN:JAN],
VePESID (TN),
4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside,
Etoposide,(S),
(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f],
EVP,
Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[4,6-O-(1R)-ethylidene-.beta.-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-,
Etoposide [USAN:USP:INN:BAN:JAN],
Etoposide; VP-16,
Prestwick3_000396,
Demethyl Epipodophyllotoxin Ethylidine Glucoside,
AC1L1VT3,
SCHEMBL4259,
BSPBio_000611,
Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 9-((4,6-O-ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-,
MLS000049957,
MLS001074951,
MLS001424283,
MLS002153463,
MLS002207239,
MLS002222184,
[1,3]dioxol-6(5aH)-one,
Etoposide (JP17/USP/INN),
BPBio1_000673,
GTPL6815,
VJJPUSNTGOMMGY-MRVIYFEKSA-N,
HMS2052N05,
HMS2089F14,
HMS2096O13,
HMS2232L03,
HMS3713O13,
EX-A1207,
ZINC3938684,
BDBM50127140,
s1225,
AKOS007930275,
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside,
AB07572,
ACN-057122,
BCP9000669,
CCG-101165,
CS-1774,
DB00773,
EBD2157958,
Etoposide, synthetic, >=98%, powder,
LS-1214,
NC00415,
4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside,
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI),
NCGC00179504-02,
AS-35312,
CC-28332,
HY-13629,
SAM001246880,
SBI-0051910.P002,
AB00438905,
ST24047199,
A-8109,
C01576,
D00125,
13165-EP2269989A1,
13165-EP2270008A1,
13165-EP2270014A1,
13165-EP2270018A1,
13165-EP2272827A1,
13165-EP2272832A1,
13165-EP2275413A1,
13165-EP2275420A1,
13165-EP2277565A2,
13165-EP2277566A2,
13165-EP2277567A1,
13165-EP2277568A2,
13165-EP2277569A2,
13165-EP2277570A2,
13165-EP2277865A1,
13165-EP2277876A1,
13165-EP2280012A2,
13165-EP2281815A1,
13165-EP2287156A1,
13165-EP2289892A1,
13165-EP2292280A1,
13165-EP2292614A1,
13165-EP2292615A1,
13165-EP2292617A1,
13165-EP2295055A2,
13165-EP2295416A2,
13165-EP2295426A1,
13165-EP2295427A1,
13165-EP2298305A1,
13165-EP2298746A1,
13165-EP2298748A2,
13165-EP2298764A1,
13165-EP2298765A1,
13165-EP2298768A1,
13165-EP2298772A1,
13165-EP2298778A1,
13165-EP2298780A1,
13165-EP2301928A1,
13165-EP2301933A1,
13165-EP2305640A2,
13165-EP2305642A2,
13165-EP2305671A1,
13165-EP2305679A1,
13165-EP2305689A1,
13165-EP2308812A2,
13165-EP2308833A2,
13165-EP2308839A1,
13165-EP2308855A1,
13165-EP2308861A1,
13165-EP2311453A1,
13165-EP2311807A1,
13165-EP2311808A1,
13165-EP2311825A1,
13165-EP2311827A1,
13165-EP2311829A1,
13165-EP2311840A1,
13165-EP2311842A2,
13165-EP2314574A1,
13165-EP2316832A1,
13165-EP2316833A1,
13165-EP2316834A1,
13165-EP2374454A1,
AB00438905-17,
AB00438905-18,
AB00438905_19,
419E420,
C-23291,
SR-01000763196,
SR-01000763196-3,
BRD-K37798499-001-02-5,
BRD-K37798499-001-05-8,
BRD-K37798499-001-10-8,
BRD-K37798499-001-14-0,
BRD-K37798499-001-27-2,
Etoposide, British Pharmacopoeia (BP) Reference Standard,
Etoposide, European Pharmacopoeia (EP) Reference Standard,
Etoposide, United States Pharmacopeia (USP) Reference Standard,
4''-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside),
Etoposide for system suitability, European Pharmacopoeia (EP) Reference Standard,
(10r,11r,15r,16s)-16-([(2r,4ar,7r,8r,8as)-7,8-dihydroxy-2-methyl-hexahydro-2h-pyrano[3,2-d][1,3]diox,
(10R,11R,15R,16S)-16-{[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0;{3,7}.0;{11,15}]hexadeca-1(9),2,7-trien-12-one,
(5R,5aR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one,
(5R,5aR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d],
(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,3]benzodioxol-8-one,
(5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3'',4'':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside,
[5R-[5?,5a?,8a?,9?(R*)]]-9-[(4,6-?-Ethylidene-?-D-glucopyranosyl)oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6-(5aH)-one,
9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3'',4'''':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one,
Etopophos,
fytosid,
Etomedac,
Onkoposid,
Riboposid,
Celltop,
Etopos,
Exitop,
Vepeside Sandoz,
Vepeside-Sandoz,
Etoposide Teva,
Etoposide*,
Teva, Etoposide,
Epipodophyllotoxin,
Etopophos (TN),
Eto GRY,
Eto-GRY,
Eposin (TN),
Etoposide Pierre Fabre,
Etoposido Ferrer Farma,
Etoposide, (5S)-Isomer,
D09NIB,
D0B7EB,
VP16,
Etoposide (JP15/USP/INN),
Etoposide, (5a alpha)-Isomer,
Etoposide, 98% - 1G 1g,
Etoposide [USAN:BAN:INN:JAN],
VP-16 (TN),
CID36462,
DRG-0081,
ZINC03978073,
alpha-D-Glucopyranosyl Isomer Etoposide,
CS-O-01452,
Etoposide, (5a alpha,9 alpha)-Isomer,
C29-H32-O13,
Etoposide, alpha D Glucopyranosyl Isomer,
Etoposide, alpha-D-Glucopyranosyl Isomer,
VP 16 213,
VP 26-213,
E0675,
Demethyl EpipodophyllotoxinEthylidine Glucoside,
Eposin, Vepesid, VP-16, Toposar, Etoposide,
D005047,
DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE,
4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside,
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside,
4'-demethylepipodophyllotoxin 9-[4,6-O-ethyl-idene-beta-D-glucopyranoside],
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside),
518-28-5,
EPA,
Furo [3', 4': 6,7] nafto [2,3-d]-1,3-dioxol-6 (5AH)-ona, 9-[[4,6-O-(1R)-etilideno-beta-D-glucopiranosil]oxi]-5,8,8 un,9-tetrahidro-5-(4-hidroxi-3,5-dimetoxifenil)-, (5R, 5aR, 8aR, 9S)-,
Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-.beta.-D-glucopyranosyl)oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, [5R-[5.alpha.,5a.beta.,8a.alpha.,9.beta.(R*)]]-,
|
| Complexity | 969 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 10 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 588.184g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 42 |
| Hydrogen Bond Acceptor Count | 13 |
| Hydrogen Bond Donor Count | 3 |
| Isotope Atom Count | 0 |
| Molecular Weight | 588.562g/mol |
| Monoisotopic Mass | 588.184g/mol |
| Rotatable Bond Count | 5 |
| Topological Polar Surface Area | 161A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 0.6 |
GHS Hazard and Precautionary Statements
| Symbol: |   |
| Hazard Class | 6.1 |
| Hazard statements | H340-H360-H362-H371-H372-H302-H350 |
| Packing Group | Ⅲ |
| Precautionary statements | P201-P308+P313-P280-P301+P312+P330-P301+P312a-P501a-P202-P260-P263-P264-P270-P308+P311-P405-P501 |
| UN Code | UN 2811 |
Certificate of Analysis
Lot Number
Related Research Chemicals
CERTIFICATE OF ANALYSIS
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
Analysis Data:
| Test: | Result: |
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited